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Drosophila dorsal longitudinal muscles develop during metamorphosis by fusion of myoblasts with larval templates. It has been shown that
both vestigial and Notch are crucial for correct formation of these muscles. We investigated the relationship between vestigial and the Notch
pathway during this process. Using Enhancer of Split Region Transcript m6 gene expression as a reporter of Notch pathway activity, we were able
to demonstrate that this pathway is only active in myoblasts. Moreover, close examination of the cellular location of several of the main actors of
the N pathway (Notch, Delta, neuralized, Serrate, Mind bomb1 and fringe) during dorsal longitudinal muscle development enabled us to find that
Notch receptor can play multiple roles in adult myogenesis. We report that the locations of the two Notch ligands (Delta and Serrate) are different.
Interestingly, we found that fringe, which encodes a glycosyltransferase that modifies the affinity of the Notch receptor for its ligands, is expressed
in muscle fibers and in a subset of myoblasts. In addition, we demonstrate that fringe expression is essential for Notch pathway inhibition and
muscle differentiation. Lastly, we report that, in vestigial mutants, fringe expression is lost, and when fringe is overexpressed, a significant rescue
of indirect flight muscle degeneration is obtained. Altogether, our data show that a vestigial-differentiating function is achieved through the
inhibition of the Notch pathway.
© 2006 Elsevier Inc. All rights reserved.Keywords: Myogenesis; Notch pathway; Vestigial; Dorsal longitudinal musclesIntroduction
During Drosophila development, two waves of myogenesis
occur. The first, during embryogenesis, gives rise to the larval
musculature, and the second, during pupation, leads to the
formation of body wall, leg and flight muscles. Embryonic
myogenesis has been extensively studied and has brought new
insight into the processes generating differentiated muscles
from undetermined mesodermal cells (for review, see Baylies et
al., 1998). Adult myogenesis has been less studied, but flight
muscles have emerged as a suitable model for the study of
muscular differentiation. Flight muscles are located in the
thorax and are subdivided into two distinct classes: the direct
flight muscles (DFMs) involved in changing orientation of the
wing and indirect flight muscles (IFMs) contributing to flight by
deformation of the thorax. These muscles are formed from⁎ Corresponding author. Fax: +33 1 44275265.
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doi:10.1016/j.ydbio.2006.03.022precursors selected during embryogenesis that proliferate
during the three larval stages on the notal part of the wing
imaginal disc. These cells are named adepithelial cells as long as
they remain associated with the wing disc (Bate et al., 1991).
The DFMs are small tubular muscles that arise from the fusion
of the most proximal adepithelial cells that express high levels
of cut (ct) (Sudarsan et al., 2001). The IFMs, which represent
the most prominent muscles of the thorax, have a striated
structure very close to that of vertebrate muscles. They are
constituted of 6 dorsal longitudinal muscles (DLMs) and 7
dorsal ventral muscles (DVMs) per hemi segment (Crossley,
1978). The adepithelial cells involved in their formation show
specific expression of the Vestigial (VG) transcription factor
and a low level of CT (Sudarsan et al., 2001). Development of
each category of IFMs is based on two different developmental
strategies. DVMs are formed de novo, whereas, to form, DLMs
use persistent larval muscles as a scaffold. At the onset of
metamorphosis, all larval muscle fibers histolyze except for a
subset of thoracic muscles, the larval oblique muscles (LOMs;
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formation (APF), adepithelial cells have migrated from the
imaginal discs to surround the three LOMs and fusion begins.
Between 14 and 20 h APF, the three larval templates (LOMs)
vacuolate and split into six DLMs (Fernandes et al., 1991). The
fusion between developing DLMs and myoblasts is achieved at
36 h APF. Myofibers differentiate and increase in size to
complete the formation of the adult pattern (Fernandes et al.,
1991).
Myogenesis is a complex process which includes prolifer-
ation of myoblasts, their migration and physical alignment, and
finally their differentiation. The differentiation of myoblasts
results in both profound morphological and biochemical
changes. Morphologically, myoblasts fuse to form multinucle-
ated myotubes. Biochemically, myogenic differentiation is
characterized by a coordinate induction of genes encoding the
proteins necessary for the operating functions of muscle, such as
myosin and sarcomeric actin, and a repression of the genes
involved in myoblast determination and proliferation. In
Drosophila, as in vertebrates, it has been shown that activation
of the Notch (N) pathway inhibits myogenic differentiation
(Anant et al., 1998; Nofziger et al., 1999; Shawber et al., 1996).
The N pathway is an evolutionarily conserved cell–cell
signaling pathway that plays a critical role in tissue develop-
ment in many organisms. The signal receiving cell expresses the
transmembrane N receptor, and the signal sending cell
expresses the N transmembrane ligands, Serrate (SER) and/or
Delta (DL). When N binds to its ligand, it undergoes a series of
proteolytic cleavages leading to the release of the N intra-
cellular domain (NI). NI is relocalized in the nucleus where it
interacts with the Suppressor of Hairless factor (Su(H)) to
activate the targets of the N pathway (for review on N pathway,
see Lai, 2004; Mumm and Kopan, 2000; Schweisguth, 2004).
Several other factors have been involved in N signaling such as
Fringe (FNG), a glycosyltransferase that enhances N-DL
interactions by modifying N (Bruckner et al., 2000; Moloney
et al., 2000; Panin et al., 1997), and E3 ubiquitin ligases which
positively regulate the N pathway by promoting the endocytosis
of the ligands (Le Borgne et al., 2005a).
During Drosophila adult myogenesis, it has been shown by
Anant et al. that both reduction and constitutive activation of N
affect the development of IFMs but not the closely related
DFMs (1998). Moreover, the authors demonstrate that the
expression of the transcription factor TWIST (TWI), a
myogenic inhibitory factor, is under the control of N in
swarming myoblasts about 24 h APF. Ectopic expression of NI
in developing fibers leads to ectopic expression of twi and to
muscle degeneration, and thermosensitive mutants of the N
receptor show a decrease in myosin heavy chain (mhc)
expression level (Anant et al., 1998). It was then proposed
that N and TWI act as muscle differentiation inhibitors and that
N signaling could play a direct role in maintaining myoblasts in
an undifferentiated state until they are correctly positioned for
differentiation (Anant et al., 1998). In a previous study, we have
reported that flies that are homozygous for vgnull mutation
present specific degenerations of the IFMs. We have shown that
degenerating fibers exhibit ectopic expression of TWI and thatthese fibers lose the expression of the differentiation marker
Actin88F (Bernard et al., 2003). These data strongly suggest
that muscular differentiation is impaired in vgnull mutants. With
regard to the similarity of phenotypes, we investigated vg-N
interactions during Drosophila IFM formation.
So far, studies involving the Notch (N) pathway in IFM
development have been based on genetic experiments
modulating N receptor activity (Anant et al., 1998). No
experiments have as yet been performed to determine whether
core components of this pathway are expressed during this
process. We therefore began our investigation of vg-N
relationships by examining the expression and the cellular
location of several components of this pathway during DLM
development. In this paper, we describe the location of Dl, N,
fng, as well as the E3 ubiquitin ligases neuralized (neur) and
mind bomb 1 (mib1) during DLM development. We report that
the spatial patterns of the two N ligands (DL and SER) are
different during DLM formation. Then we demonstrate that the
N pathway is active only in the myoblasts. Interestingly, fng,
which encodes a glycosyltransferase that modifies the affinity
of the N receptor for its ligands, is expressed in differentiated
muscles and in a few myoblasts. In vgnull mutants, fng
expression is not detected, and an ectopic expression of N
targets is observed in developing DLMs. When fng is
overexpressed, in vgnull mutants, a significant rescue is
obtained, showing that VG's main function in adult myogen-
esis is to activate fng, which inhibits the N pathway and allows
a correct differentiation of DLMs.
Material and methods
Fly stocks
The vgnull strain was generated in our laboratory (Paumard-Rigal et al.,
1998; Zider et al., 1998). MHC-LacZ (Myosin Heavy Chain promoter), Duf-
LacZ and Enhancer of Split Region Transcript m6-GFP strains are
respectively described in Hess et al. (1989), Nose et al. (1998), and Lai et
al. (2000b). The neurP72-GAL4 and UAS-H2B∷YFP lines are described in
Bellaiche et al. (2001). UAS-CD8∷GFP strain is described in Lee and Luo
(1999). 1151-GAL4 has been described in Anant et al. (1998). The fng35UZ-1
strain comes from S. Cohen's laboratory. The UAS-fng and Nts1 strains were
described in Rauskolb and Irvine (1999) and Shellenbarger and Mohler
(1978), respectively, and were obtained from the Bloomington Drosophila
stock center (strains #5831 and 2533, respectively). UAS-NI strain is
described in Go et al. (1998).
Muscle preparation
Dissection of pupae was performed as previously described (Fernandes et
al., 1991). Adult flies were fixed in 4% paraformaldehyde overnight.
Thoraces were cut sagittally, mounted in glycerol and viewed under polarized
light.
Immunochemistry
Tissues were fixed for 1 h in 4% paraformaldehyde, washed three times in
PBT (phosphate saline buffer, 0.3% triton X100) and incubated for 1 h in PBT-
NGS (PBT, 4% normal goat serum) at 4°C. Samples were incubated overnight in
a PBT-NGS antibody solution at 4°C. Samples were washed three times in PBT
for 10 min. For fluorescence detection, samples were then incubated with
fluorescently labeled secondary antibody for 2 h, washed three times in PBT and
mounted in Citifluor (Citifluor Ltd., London, England). anti-VG, anti-TWI, anti-
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Schweisguth and K. Irvine, respectively, and were used at a 1:200, a 1:5000, a
1:200 and a 1:2000 dilution, respectively. Mouse anti-GFP (used at 1:200
dilution) and rabbit anti-GFP (used at 1:1000 dilution) antibodies were
purchased from Roche (Penzberg, Germany) and Molecular Probes (Foster
City, USA), respectively. Rabbit anti-βGAL antibody was purchased from
Cappel (Durham, NC, USA) and used at a 1:1000 dilution. Mouse anti-βGAL,
anti-CT, and anti-NI antibodies are supernatant purchased from the Develop-
mental Studies Hybridoma Bank (DSHB) and were used at a 1:200 dilution.
Anti-DL is a concentrate serum also purchased from DSHB and used at a 1:1000
dilution. Preparations were observed with a Leica TCS-SP confocal microscope.Results
N is expressed in myoblasts and in muscles fibers
We first looked for the N receptor expression in 8 h APF
Dumbfounded-LacZ (Duf-LacZ) pupae (Figs. 1A–C). In thisFig. 1. Expression of the N receptor in developing DLMs. In all panels, asterisks indic
located by βGal staining (A). N expression (B) is visualized on myoblasts (arrowhead
labeling reveals developing muscle fibers (D) and anti-NI antibodies (E) show an exp
gal4; UAS-mCD8∷GFP strain (G–I), GFP (G) is tagged to membranes. Merge in
(arrowheads).strain, βGAL was visualized in the nuclei of LOMs, which
serve as templates for DLM formation (Dutta et al., 2004),
as revealed by anti-βGAL detection (Fig. 1A, asterisks).
Anti-N labeling showed that N is expressed in myoblasts
(arrowheads) and in muscle fibers (arrows) (Fig. 1B; merge
in C). N expression persists during the development as
shown by immunodetection experiments performed in 21
h APF MHC-LacZ pupae (Figs. 1D–F). In MHC-LacZ
strain, βGAL was expressed in developing fibers according
to MHC expression pattern (Fig. 1D, asterisks). Anti-N
labeling allowed the detection of N in myoblasts between
developing fibers (Fig. 1E, m; merge in F). It was difficult,
however, to know whether N is expressed at the muscle
fiber membranes or not. To address this question, we used
an 1151-GAL4; UAS-CD8∷GFP strain. In this strain, GFP-
tagged transmembrane CD8 protein is expressed in muscles
and myoblasts and makes it possible to reveal cellate the location of muscle fibers. In 8 h APFDuf-LacZ pupae (A–C), LOMs were
s) and muscle membranes (arrows). In 21 h APFMHC-LacZ pupae (D–F), βGal
ression of the N receptor at the membrane surface of myoblasts (m). In the 1151-
panel I reveals that the N receptor (H) is also localized on membrane muscles
Fig. 2. Expression of N ligands during DLM formation. In all panels, asterisks indicate the location of muscle fibers. In 10 h APF (A–C, G–I) and 21 h APF
pupae (D–F, J–L) of MHC-LacZ strain (A–L), βGal antibodies reveal muscles fibers (A, D, G, J). Antibodies against SER show that the SER ligand (B, E)
is present at the membranes of swarming myoblasts (arrowheads) and muscles fibers (asterisks). By 10 h APF (A, C), all swarming myoblasts express SER,
as shown by a DAPI staining (in white, on merge I). Antibodies against DL (H, K) show that the DL ligand is present at the membrane surface of
developing muscles (arrows).
167F. Bernard et al. / Developmental Biology 295 (2006) 164–177membranes (Fig. 1G asterisks: muscles). Anti-N labeling
showed that N is expressed at muscle membranes (Fig. 1H,
arrow, merge in I) and at myoblast membranes (Figs. 1G–I,
arrowheads). Thus, between 8 h APF and 30 h APF, N is
detected at the membranes of both myoblasts and muscles
fibers.DL and SER are differentially expressed during DLMs
development
In Drosophila, two transmembrane proteins can activate the
N receptor: DL and SER. During Drosophila development, DL
and SER have distinct functions, possibly not because they have
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sion patterns are non-overlapping. In the sensory bristle lineages,
DL and SER have been proposed to have redundant functions
(Zeng et al., 1998). Furthermore, DL and SER appear to be
interchangeable; an overexpression of Ser can partially rescue
the Dl neurogenic phenotype (Gu et al., 1995) and, conversely,
ectopic expression of Dl can partially rescue the Ser wing
phenotype (Klein andArias, 1998). A recent study in vertebrates,
however, shows that DL and SER vertebrate homologs can have
different signaling activities (Amsen et al., 2004).
When we looked for SER expression, we did not detect any
expression before 10 h APF. In 10 h APF (Figs. 2A–C) and 21 h
APF (Figs. 2D–F) MHC-LacZ pupae, however, anti-SER
antibodies (Figs. 2B, E) revealed the presence of SER in both
developing fibers (asterisks), located by anti-βGAL labeling
(Figs. 2A, D), and swarming myoblasts (arrowheads) (merge in
Figs. 2C, F).
During DLM development, no DL expression was found at
8 h APF, and we started to detect DL expression at 10 h APF. In
10 h APF pupae of the MHC-LacZ strain (Figs. 2G–I), anti-
βGAL labeling revealed small developing fibers (Fig. 2G,
asterisks) that had begun to fuse with surrounding myoblasts.
DL expression detected by anti-DL antibodies was restricted to
developing DLMs (Fig. 2H arrows; merge in 2I). At 21 h APF
in the MHC-LacZ strain (Figs. 2J–L), muscles labeled by anti-
βGAL antibodies (Fig. 2J, asterisks) showed a strong DL
labeling at the membrane of developing fibers (Fig. 2K, merge
in L, arrows). Thus, it appears that both N ligands are expressed
during DLM formation after 10 h APF. Nevertheless, their
expressions differ spatially; DL is specifically expressed at the
membrane of developing DLMs, whereas SER is expressed in
both myoblasts and muscles.
Neur is only expressed in the developing muscle fibers
Numerous studies have emphasized the role of E3-ubiquitin
ligases in activation and regulation of the N pathway (for
review, see Le Borgne et al., 2005a). It has been shown that
internalization of ligands in signal sending cells is necessary for
the activation of the pathway in receiving cells (Le Borgne and
Schweisguth, 2003a; Le Borgne et al., 2005b; Seugnet et al.,
1997). In Drosophila, two E3-ubiquitin ligases are known to be
responsible for internalization of DL and SER. Neuralized
(NEUR) was the first to be described, and it has been reported
that NEUR positively regulates the N pathway by promoting the
endocytosis and degradation of DL (Lai et al., 2001;
Pavlopoulos et al., 2001; Le Borgne and Schweisguth,
2003b). Recently, Mind bomb 1 (MIB1), a second E3-ubiquitin
ligase, was reported to ubiquitinate both N ligands (Lai et al.,
2005; Le Borgne et al., 2005b; Pitsouli and Delidakis, 2005;
Wang and Struhl, 2005).
We looked for MIB1 expression during DLM development,
using anti-MIB1 antibodies. No expression of MIB1 was
detectable in 8 h APF animals. MIB1 expression was first
visualized at 10 h APF and persisted during DLM formation. In
the MHC-LacZ strain, 10 h APF pupae (Figs. 3A–C) showed
that MIB1 (Fig. 3B) was strongly expressed in myoblasts(arrowheads), and a faint expression was detected in muscle
fibers (asterisks) that were located by anti-βGAL labeling (Fig.
3A). Likewise, in 21 h APF pupae (Figs. 3D–F), MIB1
expression (Fig. 3E) was clearly observed at the membrane of
swarming myoblasts (arrowheads), whereas developing DLMs
showed a reduced expression (asterisks).
At 8 h APF, neur expression was monitored using the neurP72
GAL4 enhancer trap driving the H2B∷YFP transgene in a Duf-
LacZ background (Figs. 3G–I, asterisks). H2B∷YFP was
observed in the larval nuclei (Fig. 3H, red) as revealed by the
co-localization with βGAL labeling (Fig. 3G, merge in I).
Conversely, no expression was found in myoblasts labeled by
TWI antibodies (Fig. 3H, blue). Similarly, in a MHC-LacZ
background, 21 h APF pupae showed no H2B∷YFP expression
in swarming myoblasts where TWI was expressed (Fig. 3K, m).
neurP72 expression was only found in developing fibers (Fig.
3K, asterisks). Muscular expression was confirmed by MHC-
LacZ labeling (Fig. 3J, asterisks; merge in L). A similar expres-
sion pattern of neur was found with the A101 (neur-LacZ)
enhancer trap (data not shown). Muscular neur expression asso-
ciated with the presence of DL at DLM membranes strongly
suggests that muscle fibers can be considered to be signal sen-
ding cells that activate a DL-N pathway in signal receiving cells.
The Notch pathway is active in myoblasts
The N pathway is essential for the proper patterning and
development of most tissue in all metazoan organisms. This
signaling pathway regulates directly or indirectly the expression
of many genes during Drosophila development. In order to test
N activity during DLM development, we looked for a direct and
specific target of this pathway. There are two large families of
direct N target genes that are clustered in two genomic regions,
named the Enhancer of split-Complex (E(spl)-C) and the
Bearded Complex. Together, these complexes contain seven
basic helix–loop–helix repressor encoding genes and ten
Bearded genes, all of which regulate N signaling (Artavanis-
Tsakonas et al., 1999). In every process in which the N pathway
is involved, some of these genes are expressed, but each gene
has a specific pattern of expression.
We have found that Enhancer of split region transcript m6 (E
(spl)-m6) is expressed during IFM formation. E(spl)m6 encodes
a non-bHLH protein related to Bearded proteins and is encoded
by the Enhancer of Split Locus. It was already reported that E
(spl)m6 is a direct target of the N pathway that is expressed in a
subset of adepithelial cells (Lai et al., 2000a). When we looked
at E(spl)m6-GFP reporter gene expression in 8 h APFDuf-LacZ
pupae (Figs. 4A–C), we observed GFP expression (Fig. 4A) in
some myoblasts swarming around the LOMs revealed by
βGAL expression (Fig. 4B, merge in C). At 21 h APF E(spl)
m6-GFP reporter gene was expressed in swarming myoblasts
(Fig. 4D) revealed by a TWI labeling (Fig. 4E, merge in F). No
labeling was found in developing fibers (Figs. 4D–F, asterisks).
These findings suggest that the N pathway is active in
myoblasts and inactive in developing fibers. We had, however,
to verify that E(spl)m6-GFP is a N pathway target in swarming
myoblasts like in adepithelial cells, as well as whether the N
Fig. 3. neur and MIB1 expressions during DLM development. In all panels, asterisks indicate the location of muscle fibers. In 10 h APF (A–C) and 21 h APF (D–F)
MHC-LacZ pupae, βGal antibodies revealed muscles fibers (A–D) and anti-MIB1 antibodies (B–E) show the presence of MIB1 protein in myoblasts (arrowheads) and
developing muscles. In order to look at neur expression by 8 h APF (G–I), we crossed the neurP72; UAS H2B∷YFP strain with Duf-LacZ strain. Pupae of the progeny
stained with βGAL (G) and TWI (H, blue staining) antibodies revealed that neur expression (H, red staining) is restricted to muscle fibers (merge in panel I). The fact
that not all the nuclei of LOMs appear to express βGAL is due to confocal Z sections. To look at neur expression by 21 h APF (J–L), we similarly crossed the neurP72;
UAS H2B∷YFP strain with theMHC-LacZ strain. At this stage, neur expression (K, red staining) is still restricted to muscle fibers located by βGAL labeling (J). Anti-
TWI staining (K, blue staining) confirms that no neur expression is visualized in myoblasts (m).
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Thus, we looked for E(spl)m6-GFP expression in Nts1 genetic
context (Figs. 4G–J). Since twi is not expressed in Nts1 genetic
context (Anant et al., 1998), it could not be used to label
myoblasts. To bypass this problem, we used DAPI to label allnuclei (Fig. 4I) associated with a MHC-LacZ labeling to detect
muscle fibers (Fig. 4G). Overlay of the two labelings enabled us
to distinguish myoblast nuclei (arrowheads, merge in Fig. 4J)
from muscle nuclei (asterisks, merge in Fig. 4J). No E(spl)m6-
GFP expression was detected in myoblasts at restrictive
Fig. 4. E(spl)m6 is a target of the N pathway and is specifically expressed in swarming myoblasts. In all panels, asterisks indicate the location of muscle fibers. To look
at E(spl)m6 expression in 8 h APF pupae (A–C), we crossed the E(spl)m6-GFP strain with the Duf-LacZ strain. In 8 h APF pupae of the progeny, staining with βGal
antibodies (B) locates LOMs, and anti-GFP antibodies (A) revealed the expression of E(spl)m6-GFP transgene in swarming myoblasts only. DAPI labeling (in white,
on merge in panel C) show that at the 8 h APF E(spl)m6-GFP transgene is not expressed in all myoblasts. In 21 h APF pupae of E(spl)m6-GFP strain (D–F), anti-TWI
antibodies (E) show that transgene expression (D) is only detectable in myoblasts surrounding developing fibers. Merge in panel F reveals that all TWI-expressing cells
are GFP positives. In Nts1;MHC-LacZ pupae grown under restrictive conditions (G–J), anti-βGAL labeling reveals muscle fibers (G, asterisks). DAPI staining shows
nuclei (I). Nuclei outside the developing fibers (arrowheads, merge in panel J) belong to swarming myoblasts. No E(spl)m6-GFP expression (H) is detectable in
myoblasts (arrowheads) or developing fibers (asterisks), confirming that E(spl)m6 is a target of the N pathway in swarming myoblasts. When NI is overexpressed in
1151-Gal4, UAS-NI, E(spl)m6-GFP flies, staining with TWI (K) and GFP (L) antibodies reveals ectopic E(spl)m6-GFP expression in muscle fibers, as well as TWI.
Merge in panel M.
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GFP is a N pathway target in swarming myoblasts. We next
verified that ectopic activation of the N pathway in developing
fibers could lead to ectopic expression of E(spl)m6-GFP. We
overexpressed NI in myoblasts and developing fibers using the1151-GAL4 driver. As previously described, an ectopic
expression of TWI can be detected in developing fibers (Fig.
4K). Moreover, an ectopic expression of E(spl)m6-GFP was
observed in fibers (Fig. 4L, merge in M). Thus, ectopic
activation of the N pathway in developing fibers leads to ectopic
171F. Bernard et al. / Developmental Biology 295 (2006) 164–177activation of E(spl)m6-GFP. These results clearly demonstrate
that the N pathway is activated in myoblasts and not in
developing fibers.
fng is expressed in a subset of myoblasts
We found that both N ligands are expressed during DLM
formation, and that activity of the N pathway is detected only in
swarming myoblasts. Moreover, it has been shown that
activation of the N receptor by its ligands is influenced by
glycosyltransferases that participate in the synthesis of O-linked
fucose glycans attached to its extra-cellular domain (reviewed in
Haines and Irvine, 2003). O-linked fucose is a substrate for
β1,3-N-acetylglucosaminyltransferases encoded by fringe (fng)
gene. Glycosylation by Fringe exerts a positive influence on
DL-N signaling but a negative influence on SER-N signaling
(Bruckner et al., 2000; Moloney et al., 2000).
We subsequently looked for fng expression, using the
fng35UZ-1 reporter. In 8 h APF pupae, fng expression (Fig.
5A) was detected in a subset of swarming myoblasts (arrow-
heads) as revealed by TWI labeling (Fig. 5B, merge in C).
Similarly, in 21 h APF fng35UZ-1 pupae (Figs. 5D–F), anti-
βGAL antibodies revealed fng expression (Fig. 5D) in only a
small proportion of swarming myoblasts detected by anti-TWI
antibodies (Fig. 5E, merge in F) and in muscles fibers
(asterisks). Muscular expression of fng became detectable
from 16 h APF (data not shown). Interestingly, fng-expressing
myoblasts seems to be very close to the DL-expressing
developing fibers (Figs. 5D–F, arrowheads), suggesting that
these myoblasts will shortly fuse and thus differentiate soon.
Since the N pathway is known to inhibit differentiation, we
wanted to find out whether N activity differed in fng-expressing
and non-expressing myoblasts. We, therefore, looked to see
whether or not fng expression was correlated with differential
expression of E(spl)m6-GFP transgene. In 21 h APF fng-LacZ,
E(spl)m6-GFP pupae (Figs. 5G–I, region boxed is magnified in
Figs. 5G′–I′), βGAL labeling (Figs. 5G, G′) revealed that fng-
expressing myoblasts showed no expression (white arrowhead)
or a reduced expression (yellow arrowhead) of GFP (Figs. 5H,
H′) compared to fng non-expressing myoblasts (arrows) (merge
Figs. 5I, I′). Thus, it is likely that fng represses E(spl)m6
expression.
VG represses the N pathway in developing DLMs
A previous study has shown that ectopic activation of the N
pathway in developing fibers leads to ectopic expression of twi
(Anant et al., 1998). Moreover, we have previously shown that
loss of vg induces an ectopic reactivation of twi in developing
fibers after 24 h APF (Bernard et al., 2003). Thus, we propose
that absence of VG in developing fibers could lead to N
pathway ectopic activation and finally to TWI expression. To
address these questions, we looked for E(spl)m6-GFP reporter
gene expression in vgnull developing fibers. No ectopic
expression of E(spl)m6-GFP was seen in developing fibers of
vgnull pupae about 24 h APF (data not shown). In 30 h APF vg+
developing fibers, MHC-LacZ transgene allowed the visualiza-tion of developing fibers (Fig. 6A, asterisks). E(spl)m6-GFP
was exclusively expressed in swarming myoblasts at this stage
(Fig. 6B, merge in C). In 30 h APF vgnull pupae, developing
fibers, located by MHC-LacZ expression (Fig. 6D, asterisks),
ectopically expressed the E(spl)m6-GFP reporter gene (Fig. 6E,
merge in F). Thus, since the absence of VG in developing
DLMs leads to N pathway activation about 30 h APF, we
conclude that VG represses the N pathway in developing
DLMs.
fng is responsible for repression of the N pathway in
developing fibers
In order to understand the mechanisms leading to N
derepression in vgnull developing DLMs, we first looked for
N actor expression in DLMs of vgnull homozygous fly. N, DL,
SER expressions did not change compared to vg+ controls (data
not shown). On the other hand, fng expression monitored by the
fng35UZ-1 reporter gene was completely lost during DLM
formation. In 21 h APF vgnull/vgnull pupae, anti-βGAL
antibodies did not reveal any expression of fng (Fig. 7A) either
in muscle fibers (asterisks) or in swarming myoblasts located by
TWI (Fig. 7B, merge in C). This result shows that VG is
required for fng expression during DLM development. We then
decided to overexpress FNG in myoblasts and developing fibers
of homozygous vgnull pupae using the 1151-GAL4 driver and
looked for E(spl)m6-GFP in developing muscles at 30 h APF
(Figs. 7D–F). Fibers and myoblasts were visualized by an anti-
CT labeling (Fig. 7D, asterisk for muscles). No ectopic
expression of E(spl)m6-GFP was seen in developing fibers
(Fig. 7E, asterisks, merge in F), showing that FNG expression is
sufficient to repress the N pathway in developing fibers, even in
the absence of VG. We subsequently looked at adults
overexpressing FNG in vgnull genetic context according to the
1151-GAL4 driver (Figs. 7G–H). A significant rescue of muscle
degeneration phenotype was observed (Fig. 7H) compared to
controls (no FNG overexpression, Fig. 7G). Thus, FNG
repression of the N pathway in developing DLMs is a key
feature of their development: absence of fng expression leads to
N derepression and finally to muscle degeneration. Thus, it
appears that the main function of VG is to activate fng, either
directly or indirectly, to allow correct development of DLMs.
Discussion
A previous study stated that the N pathway is required to
maintain twi expression in swarming myoblasts and inhibit
muscle differentiation (Anant et al., 1998). These authors
proposed two models to explain N function during DLM
development. The first model proposed was based on a
mechanism of ‘lateral inhibition’, where a ‘founder cell’ is
chosen from a pool of myoblasts and the N receptor functions in
other myoblasts to receive signals that inhibit these myoblasts
from becoming founder cells. The recent description of a
‘founder cell’marker in adult myogenesis, the duf gene, allowed
VijayRaghavan and coworkers to test this model. It was
challenged by the demonstration that selection of duf-
Fig. 5. fng expression is restricted to a subset of myoblasts. In all panels, asterisks indicate the location of muscle fibers. In order to characterize fng expression during
DLM formation, we used the fng35UZ-1 reporter gene. In 8 h APF (A–C), anti-βGal antibodies show fng expression (B) in myoblasts only. Anti-TWI labeling (A)
reveals that only a subset of TWI-expressing myoblasts is fng-positive (arrowheads) (merge in panel C). In 21 h APF fng35UZ-1 pupae, staining with βGal (D) and TWI
(E) antibodies shows fng expression in muscles and in some swarming myoblasts, as revealed by co-localization of TWI (green) and βGAL (red) staining (arrowheads)
in the merged picture (F). To examine the correlation between E(spl)m6 and fng expression, we crossed fngUZ35-1 and E(spl)m6-GFP strains. In the progeny, 21 h APF
pupae anti-GFP (H) and βGAL (G) antibodies show that fng-expressing myoblasts show either reduced (yellow arrowheads) or no expression (white arrowheads) of E
(spl)m6-GFP transgene, compare to fng non-expressing myoblasts (arrows) (merge in panel I). Panels G′–I′ are a magnification of the region boxed in panels G–I.
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Fig. 6. E(spl)m6 derepression in vgnull genetic context. In all panels, asterisks indicate the location of muscle fibers. In control 30 h APF E(spl)m6-GFP; MHC-LacZ
pupae, staining with βGAL antibodies reveals developing fibers (A). E(spl)m6-GFP expression (B) is detectable in swarming myoblasts only (merge in panel C). In
vgnull homozygous,MHC-LacZ, E(spl)m6-GFP 30 h APF pupae, anti-βGAL staining reveals developing fibers (D, asterisks). E(spl)m6-GFP is ectopically expressed
in developing fibers (E, asterisks, merge in panel F), showing that the N pathway is ectopically activated in a vgnull genetic context.
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adult myogenesis (Dutta et al., 2004). The second model
proposed by Anant et al. was that N signaling is directly
involved in maintaining myoblasts in an undifferentiated state
until they are correctly positioned to receive the appropriate
environmental signals to differentiate. According to this model,
in Nts conditions, myoblasts express differentiation markers, but
degeneration of adult muscles have also been reported (Anant et
al., 1998), suggesting that the N receptor probably plays an
additional role. The close examination of the cellular locations
of several components of the N pathway during DLM
development that we report in this paper, as well as the role
of fng, enable us to complete this model and further suggest that
during DLM formation N function is multiple.
Indeed, we have observed that the N receptor is expressed in
myoblasts and in muscle fibers from 8 h APF and persists
during development (Fig. 1). By 10 h APF, expression of the
two known N ligands begins. DL is specifically expressed in
developing fibers, whereas SER is expressed in both swarming
myoblasts and developing fibers (Fig. 2). The signaling
properties of these ligands have been demonstrated to require
endocytosis (Le Borgne and Schweisguth, 2003a; Le Borgne et
al., 2005b; Seugnet et al., 1997). Until today, two proteins have
been shown to be involved in endocytosis and activation of N
ligands: NEUR and MIB1 (Lai et al., 2001, 2005; Pavlopoulos
et al., 2001; Le Borgne et al., 2005b; Pitsouli and Delidakis,
2005; Wang and Struhl, 2005). These proteins have similar
molecular activities but different developmental functions inDrosophila (Lai et al., 2005; Le Borgne et al., 2005b; Pitsouli
and Delidakis, 2005; Wang and Struhl, 2005). We found that
during DLM development, neur is only expressed in developing
muscles (Figs. 3G–L), whereas MIB1 is expressed in both
myoblasts and developing fibers (Figs. 3A–F).
Thus, the nature of these locations, together with that of N
ligand locations, strongly suggests that developing DLMs send
a DL signal, and that a SER signal is sent by myoblasts and/or
developing DLMs. When using the E(spl)m6-GFP reporter
gene, we only detected an activity of the N pathway in
myoblasts surrounding the muscle fibers. This observation is
consistent with the fact that TWI expression in swarming
myoblasts in under the control of the N pathway (Anant et al.,
1998). When we expressed the intracellular part of the N
receptor, using the 1151-GAL4 driver, we observed E(spl)m6-
GFP expression in developing DLMs, showing that the absence
of E(spl)m6-GFP muscular expression does indeed reflect an
absence of N signaling in muscles. Lastly, when we looked for
fng expression during DLM development, we observed that, at
any given time, a subset of myoblasts-expressing fng is located
in the vicinity of developing fibers-expressing DL. FNG is a
glycosyltransferase that enhances DL-N signaling and inhibits
SER-N signaling (Bruckner et al., 2000; Moloney et al., 2000).
Thus, myoblasts that express fng are likely to be receiving cells
for DL signaling sent by developing DLMs. Moreover, we
report that fng-expressing myoblasts have either reduced or no
expression of E(spl)m6 (Figs. 5G–I), strongly suggesting that E
(spl)m6 is a target of SER-N signaling and is not activated when
Fig. 7. fng involvement in muscle degeneration. vgnull/vgnull, fng35UZ-1 21 h APF pupae stained with TWI (A) and βGal (B) antibodies show no fng35UZ-1 reporter gene
expression (merge in panel C). In vgnull homozygous, 1151-GAL4,UAS-fng, E(spl)m6-GFP 30 h APF pupae, CT is expressed in swarming myoblasts (arrowheads) and
developing fibers (asterisks), as revealed by anti-CT labeling (D). E(spl)m6-GFP is still expressed in myoblasts (E, arrowheads) but is not expressed in developing
DLMs (E, asterisks, merge in panel F). Adult thoraces of vgnull/vgnull, 1151-GAL4 show typical muscle degeneration (G). Adult thoraces of vgnull/vgnull, 1151-GAL4
UAS-fng genotype show a significant rescue of muscle degeneration (H) compared to thoraces of vgnull/vgnull genotype (G).
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muscular expression of fng. We monitored fng expression using
the fng-LacZ35UZ-1 reporter gene, and thus, we cannot exclude
that muscular expression could be a perdurance of βGAL
protein after the fusion of fng-expressing myoblasts. Neverthe-
less, an overexpression of fng in the vgnull context is sufficient
to repress the ectopic expression of E(spl)m6 in developing
fibers (Figs. 6D–F), strongly suggesting that fng is in part
responsible for N pathway repression in muscles.
All together, these findings support the hypothesis that there
are two N signaling pathways: a DL-N pathway with DLMs as
sending cells and fng-expressing myoblasts as receiving cells
and a SER-N pathway between fng non-expressing myoblasts
and possibly between DLM fibers and fng non-expressing
myoblasts. We propose that the SER-N pathway could be
responsible for maintaining myoblasts in a state of proliferation
and undifferentiation, whereas the DL-N pathway could
regulate differentiation. Thus, the SER-N pathway would be
responsible for the expression of specific myoblast markerssuch as E(spl)m6 and TWI. Our results show that fng expression
is necessary for correct DLM development. This function could
be achieved by either simply inhibiting activation of the N
receptor by SER or allowing a DL-N signaling that inhibits E
(spl)m6 expression. Nevertheless, when we overexpressed fng
using the 1151-GAL4 driver, we still observed swarming
myoblasts-expressing E(spl)m6, showing that fng expression
alone is not sufficient to repress N pathway activity in swarming
myoblasts and suggesting rather that DL-N signaling could be
involved in this inhibition process. Thus, a DL-N pathway
could induce a differentiation factor responsible for muscle
differentiation. To complete the testing of this model, the role of
each ligand needs to be examined by loss of function
experiments, but the lethality of Ser and Dl mutants and the
impossibility to generate mitotic clones in muscles make this
difficult.
We have previously reported that vgnull flies exhibit specific
IFM degenerations, and that degenerating DLMs show an
ectopic expression of TWI and a loss of Act88F expression,
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pathway occurs (Bernard et al., 2003). In this paper, we report
that, in a vgnull context, the ectopic expression of E(spl)m6, a
direct target of N signaling, normally restricted to myoblasts,
can be visualized in developing fibers (Figs. 6A–F). We show
that this ectopic expression is associated with the lack of fng
expression (Figs. 7A–C). Moreover, we show that an over-
expression of fng in vgnull animals is sufficient to rescue the
muscular phenotype of these animals (Figs. 7D–I). These data
demonstrate that VG is necessary for fng expression during
adult myogenesis. VG alone is not sufficient, however. First,
VG is expressed in all swarming myoblasts, whereas fng
expression is restricted to a subset of myoblasts, and secondly,
overexpression of VG by means of the 1151-GAL4 driver did
not induce a larger number of fng-expressing myoblasts
compared to the wild type situation (data not shown).
Nevertheless, taken together, our data show that VG is
necessary for muscle differentiation during DLM development,
since its absence is associated with overexpression of the N
pathway and TWI, a myogenic inhibitory factor, and with the
absence of Act88F expression, an isoform specific to muscle
differentiation (Bernard et al., 2003; this work). Moreover, in
this study, we show that the differentiation properties of VG are
linked to an inhibition of the N pathway activity.
Another study, performed during chick limb myogenesis, has
reported that Delta1 is expressed in differentiating cells and
triggers the N pathway in undifferentiated cells that express
Notch1 (Delfini et al., 2000). These locations are very similar to
the N and DL locations found during DLM development.
Moreover, we demonstrate that the N pathway is active in
undifferentiated swarming myoblasts and must be inhibited in
muscles to allow correct differentiation. Similarly, in verte-
brates, activation of the N pathway inhibits myogenic
differentiation (Delfini et al., 2000; Nofziger et al., 1999;
Shawber et al., 1996). The mechanisms responsible for this
inhibition, however, have not been clearly established and seem
to be multiple. Indeed, ex vivo experiments have demonstrated
that a canonical N signaling that leads to E(spl) homolog
activation (i.e., Hes and Hey families of genes) is rapidly
induced by N activation in C2C12 cells, and this induction is
correlated with an inhibition of differentiation (Jarriault et al.,
1998). NI has also been shown to bind to MEF2C protein and to
inhibit its cooperative activity with MyoD and myogenin
necessary for the activation of myogenesis (Wilson-Rawls et al.,
1999).
For a long time, vg has been considered to be the “wing
selector gene”, but this concept has been recently revisited
because this protein is required during adult myogenesis
(Bernard et al., 2003; Sudarsan et al., 2001). Several studies
performed in wing imaginal disc, however, have demonstrated
that VG, which is devoid of a DNA-binding domain, forms a
heterodimeric transcription factor with the protein encoded by
scalloped (sd) (Halder et al., 1998; Simmonds et al., 1998;
Vaudin et al., 1999). VG protein has little homology with any
known proteins in Drosophila, except for a N-terminal domain
resembling that of the protein Paired, but the domain of
interaction between VG and SD seems to be conserved acrossevolution and has made it possible to describe several vg
homologs in vertebrates vestigial like 1, 2, and 4 (vgll1, 2, and
4) (Chen et al., 2004; Maeda et al., 2002; Mielcarek et al.,
2002). In mouse, vgll2 is expressed in skeletal muscles, whereas
vgll4 is expressed in cardiac muscle (Chen et al., 2004).
Interestingly, VG and Vgll2 (former Vgl-2 and VITO-1) in their
respective functions have multiple features in common. Indeed,
vg is expressed in adult DLM, swarming myoblasts and
developing fibers (Bernard et al., 2003), and Vgll2 is expressed
in chick skeletal muscles (Chen et al., 2004) as well as in C2C12
myoblasts and differentiated C2C12 myotubes (Mielcarek et al.,
2002). Several sets of evidence have been reported which show
that Vgll2 is necessary for muscle differentiation. Antisense-
Vgll2 morpholinos block Vgll2 and myosin expression in
C2C12 cells (Chen et al., 2004). Lastly, co-expression of Vgll2
and MyoD enhances Myo-D induced differentiation of 10T1/2
cells with a 7-fold increase in myosin heavy chain expression
(Maeda et al., 2002). In Drosophila, flies homozygous for the
vgnull mutation exhibit strong DLM degeneration and have no
DVMs. Moreover, absence of vg is associated with a loss of
Actin88F gene expression and an ectopic expression of TWI
(Bernard et al., 2003). In this present paper, we confirm that vg
plays a role in muscle differentiation and show that this role is
achieved by regulating the N pathway. These data suggest that
vertebrate myogenesis and DLM development share biochem-
ical processes and genetic cascades to give rise to a muscle fiber.
Thus, it should be interesting to test whether vgll2 regulates the
N pathway during vertebrate myogenesis.
SD is also expressed during DLM development (Bernard et
al., 2003) and is related to the Transcriptional Enhancer Factor 1
(TEF1) family of proteins which are involved in muscle
differentiation (Maeda et al., 2002). In vertebrates, these proteins
were first identified as proteins that bind to MCAT elements
(originally defined as a muscle-specific cytidine adenosine
thymidine sequence) which are required for high levels of
promoter activity in cardiac and skeletal muscle cells (Mar and
Ordahl, 1988, 1990). Similar MCAT elements have been
characterized in a large number of skeletal and cardiac muscle-
specific promoters (Larkin et al., 1996). Moreover, it has been
demonstrated that VGLL2 could physically interact with MEF2
and TEF1 proteins (Maeda et al., 2002). Interestingly, it was
recently reported that the Drosophila MEF2 homolog is
expressed, like vg, in both swarming myoblasts and developing
DLMs (Baker et al., 2005). VGLL2 is able to activate TEF-1 and
MEF2-dependent promoters in myotubes but not in myoblasts
(Maeda et al., 2002). It will be interesting to find out whether
VG, SD and MEF2 can physically interact and activate specific
muscle targets to promote muscle differentiation. Among the
various types of muscles in Drosophila, IFMs are unique with
respect to their fibrillar organization and the specific expression
of different isoforms of structural proteins (Crossley, 1978).
Thus, VG functions in muscle differentiation might also be
linked to a direct activation of these genes by the VG-SD
heterodimeric transcription factor.
In conclusion, many lines of evidence suggest that the DLM
differentiation process might be conserved between Drosophila
and vertebrates and might be one of the basic principles of
176 F. Bernard et al. / Developmental Biology 295 (2006) 164–177striated muscle differentiation. Interestingly, IFMs are the only
muscles in Drosophila that exhibit a sarcomeric organization
with continuous Z-bands (Crossley, 1978). Therefore, the results
obtained from studies of IFM differentiation should lead to a
better understanding of the process of myogenesis in vertebrates.
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